The global Zollinger-Ellison syndrome (ZES) treatment market has been witnessing steady growth in recent years, driven by the rising prevalence of gastric acid-related disorders and advancements in targeted therapies. Valued at USD 1,346.05 million in 2023, the market is projected to grow from USD 1,404.06 million in 2024 to USD 1,988.13 million by 2032,...